Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Summary

To determine the safety of prophylaxis with Tinzaparin low molecular weight heparin in primary brain tumor patients. 2. To determine the incidence of deep venous thrombosis or pulmonary embolism in brain tumor patients who will be receiving Tinzaparin as primary prophylaxis. 3. To determine the overall survival of patients with malignant glioma who receive Tinzaparin. 4. To determine the bone density before and after prophylactic Tinzaparin.

Timeline

Start

2004-02

Primary completion

2007-03

Completion

2009-10

Drugs

Indications